Treatment of gastroparesis: a multidisciplinary clinical review

Abstract  This clinical review on the treatment of patients with gastroparesis is a consensus document developed by the American Motility Society Task Force on Gastroparesis. It is a multidisciplinary effort with input from gastroenterologists and other specialists who are involved in the care of patients with gastroparesis. To provide practical guidelines for treatment, this document covers results of published research studies in the literature and areas developed by consensus agreement where clinical research trials remain lacking in the field of gastroparesis.

[1]  R. Bisschops,et al.  Influence of ghrelin on gastric emptying and meal‐related symptoms in idiopathic gastroparesis , 2005, Alimentary pharmacology & therapeutics.

[2]  P. Moayyedi,et al.  American gastroenterological association technical review on the evaluation of dyspepsia. , 2005, Gastroenterology.

[3]  T. Ohtsubo,et al.  Efficacy of Itopride Hydrochloride on Gastric Emptying in Patients with Diabetic Gastroparesis: 885 , 2005 .

[4]  M. Kamm,et al.  Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study , 2005, Gut.

[5]  A. Zinsmeister,et al.  Effect of alvimopan and codeine on gastrointestinal transit: a randomized controlled study. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[6]  J. Forster,et al.  Chronic Gastric Electrical Stimulation for Gastroparesis Reduces the Use of Prokinetic and/or Antiemetic Medications and the Need for Hospitalizations , 2005, Digestive Diseases and Sciences.

[7]  M. Detke,et al.  Duloxetine vs. placebo in patients with painful diabetic neuropathy , 2005, Pain.

[8]  T. Abell,et al.  Pilot Study on Gastric Electrical Stimulation on Surgery-associated Gastroparesis: Long-term Outcome , 2005, Southern medical journal.

[9]  R. Fisher,et al.  Endoscopic pyloric injection of botulinum toxin A for the treatment of refractory gastroparesis. , 2005, Gastrointestinal endoscopy.

[10]  T. Abell,et al.  Temporary gastric electrical stimulation with orally or PEG-placed electrodes in patients with drug refractory gastroparesis. , 2005, Gastrointestinal endoscopy.

[11]  T. Abell,et al.  Is gastric electrical stimulation superior to standard pharmacologic therapy in improving GI symptoms, healthcare resources, and long‐term health care benefits? , 2005, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[12]  M. Camilleri,et al.  Contributions of gastric volumes and gastric emptying to meal size and postmeal symptoms in functional dyspepsia. , 2004, Gastroenterology.

[13]  C. Pamer,et al.  Tardive dyskinesia risks and metoclopramide use before and after U.S. market withdrawal of cisapride. , 2004, Journal of the American Pharmacists Association : JAPhA.

[14]  R. Fisher,et al.  American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis. , 2004, Gastroenterology.

[15]  K. Murray,et al.  Relationship between area deprivation and the anticaries benefit of an oral health programme providing free fluoride toothpaste to young children. , 2004, Community dentistry and oral epidemiology.

[16]  K. Kline,et al.  Role of Topiramate for the Treatment of Painful Diabetic Peripheral Neuropathy , 2004, Pharmacotherapy.

[17]  Ling Wang.  Clinical observation on acupuncture treatment in 35 cases of diabetic gastroparesis. , 2004, Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan.

[18]  H. Das,et al.  Comparative evaluation of the efficacy and tolerability of itopride hydrochloride and domperidone in patients with non-ulcer dyspepsia. , 2004, The Journal of the Association of Physicians of India.

[19]  R. McCallum,et al.  Treatment of diabetic gastroparesis by high-frequency gastric electrical stimulation. , 2004, Diabetes care.

[20]  D. Revicki,et al.  Gastroparesis Cardinal Symptom Index (GCSI): Development and validation of a patient reported assessment of severity of gastroparesis symptoms , 2004, Quality of Life Research.

[21]  M. Tawfik,et al.  Use of transdermal fentanyl without prior opioid stabilization in patients with cancer pain , 2004, Current medical research and opinion.

[22]  J. Duby,et al.  Diabetic neuropathy: an intensive review. , 2004, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[23]  W. Hasler,et al.  Ginger Reduces Hyperglycemia-Evoked Gastric Dysrhythmias in Healthy Humans: Possible Role of Endogenous Prostaglandins , 2003, Journal of Pharmacology and Experimental Therapeutics.

[24]  J. Rosenstock,et al.  The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. , 2003, Diabetes care.

[25]  M. Horowitz,et al.  Nutrition therapy for diabetic gastroparesis , 2003, Current diabetes reports.

[26]  I. Hayashi,et al.  Effect of mosapride on glycemic control and gastric emptying in type 2 diabetes mellitus patients with gastropathy. , 2003, Diabetes research and clinical practice.

[27]  H. Parkman,et al.  Effect of prostoglandin inhibition with ketorolac on gastric activity and dyspeptic symptoms in patients with dyspeptic symptoms , 2003, American Journal of Gastroenterology.

[28]  D. Moore,et al.  The efficacy of acupressure and acustimulation wrist bands for the relief of chemotherapy-induced nausea and vomiting. A University of Rochester Cancer Center Community Clinical Oncology Program multicenter study. , 2003, Journal of pain and symptom management.

[29]  Warren Starkebaum,et al.  Gastric electrical stimulation for medically refractory gastroparesis. , 2003, Gastroenterology.

[30]  R. Lehmann,et al.  Glucose control is not improved by accelerating gastric emptying in patients with type 1 diabetes mellitus and gastroparesis. a pilot study with cisapride as a model drug. , 2003, Experimental and clinical endocrinology & diabetes.

[31]  T. Abell,et al.  Gastric electrical stimulation for gastroparesis improves nutritional parameters at short, intermediate, and long-term follow-up. , 2003, JPEN. Journal of parenteral and enteral nutrition.

[32]  D. Revicki,et al.  Development and validation of a patient‐assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index , 2003, Alimentary pharmacology & therapeutics.

[33]  M. Camilleri,et al.  Gastric accommodation and emptying in evaluation of patients with upper gastrointestinal symptoms. , 2003, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[34]  G. Tougas,et al.  Tegaserod improves gastric emptying in patients with gastroparesis and dyspeptic symptoms , 2003 .

[35]  J. Tack,et al.  Effect of intrapyloric injection of botulinum toxin on gastric emptying and meal-related symptoms in gastroparesis , 2003 .

[36]  B. Geypens,et al.  Symptoms Associated With Impaired Gastric Emptying of Solids and Liquids in Functional Dyspepsia , 2003, American Journal of Gastroenterology.

[37]  E. Van Cutsem,et al.  Gastric Electrical Stimulation in Intractable Symptomatic Gastroparesis , 2003, Digestion.

[38]  N. Talley.  Diabetic Gastropathy and Prokinetics , 2003, American Journal of Gastroenterology.

[39]  Michael P. Jones,et al.  Oral Erythromycin and Symptomatic Relief of Gastroparesis: A Systematic Review , 2003, American Journal of Gastroenterology.

[40]  P. Watkins,et al.  Long‐term outcome after gastrectomy for intractable diabetic gastroparesis , 2003, Diabetic medicine : a journal of the British Diabetic Association.

[41]  Satish S. C. Rao,et al.  Attenuation of isolated pyloric pressure waves in gastroparesis in response to botulinum toxin injection: a case report. , 2002, Gastrointestinal endoscopy.

[42]  Michael P. Jones.  Access options for withdrawn motility-modifying agents , 2002, American Journal of Gastroenterology.

[43]  M. Lefkowitz,et al.  Tegaserod, a 5-hydroxytryptamine type 4 receptor partial agonist, is devoid of electrocardiographic effects , 2002, American Journal of Gastroenterology.

[44]  K. Skole.  Efficacy of gastric electrical stimulation for gastroparesis refractory to medical therapy; a single center experience , 2002 .

[45]  R. Koretz.  The Science and Practice of Nutrition Support: A Case-Based Core Curriculum , 2002 .

[46]  K. Usadel,et al.  Long‐term cisapride treatment improves diabetic gastroparesis but not glycaemic control , 2002, Alimentary pharmacology & therapeutics.

[47]  R. Fisher,et al.  Treatment of idiopathic gastroparesis with injection of botulinum toxin into the pyloric sphincter muscle , 2002, American Journal of Gastroenterology.

[48]  P. Kranke,et al.  The Efficacy and Safety of Transdermal Scopolamine for the Prevention of Postoperative Nausea and Vomiting: A Quantitative Systematic Review , 2002, Anesthesia and analgesia.

[49]  M. Bhutani,et al.  Pyloric injection of botulinum toxin for treatment of diabetic gastroparesis. , 2002, Gastrointestinal endoscopy.

[50]  M. Crowell,et al.  Botulinum toxin for the treatment of gastroparesis: a preliminary report , 2002, American Journal of Gastroenterology.

[51]  Teresa Cutts,et al.  Predictors of Response to a Behavioral Treatment in Patients with Chronic Gastric Motility Disorders , 2002, Digestive Diseases and Sciences.

[52]  R. Hellman,et al.  Acute effect of clonidine on gastric emptying in patients with diabetic gastropathy and controls , 2002, Alimentary pharmacology & therapeutics.

[53]  P. Kranke,et al.  Dimenhydrinate for prophylaxis of postoperative nausea and vomiting: a meta‐analysis of randomized controlled trials , 2002, Acta anaesthesiologica Scandinavica.

[54]  J. Kinser,et al.  Does intravenous ondansetron affect gastric emptying of a solid meal, gastric electrical activity or blood hormone levels in healthy volunteers? , 2002, Alimentary pharmacology & therapeutics.

[55]  D. Escande,et al.  Gastrointestinal prokinetic drugs have different affinity for the human cardiac human ether-à-gogo K(+) channel. , 2001, The Journal of pharmacology and experimental therapeutics.

[56]  Y. Gupta,et al.  Reversal of pyrogallol-induced delay in gastric emptying in rats by ginger (Zingiber officinale). , 2001, Methods and findings in experimental and clinical pharmacology.

[57]  C. Beglinger,et al.  Tegaserod, a 5‐HT4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects , 2001, Alimentary pharmacology & therapeutics.

[58]  J. Foss.  A review of the potential role of methylnaltrexone in opioid bowel dysfunction. , 2001, American journal of surgery.

[59]  M. Horowitz,et al.  Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. , 2001, Archives of internal medicine.

[60]  N. Talley,et al.  Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial , 2001, Gut.

[61]  J. Wishart,et al.  Predictors of delayed gastric emptying in diabetes. , 2001, Diabetes care.

[62]  F. Fulfaro,et al.  Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: a prospective study. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[63]  R. Clouse,et al.  Tricyclic antidepressants for persistent or recurrent vomiting in diabetic patients , 2001 .

[64]  E H Wagner,et al.  Quality improvement in chronic illness care: a collaborative approach. , 2001, The Joint Commission journal on quality improvement.

[65]  N. Talley,et al.  Failure of a motilin receptor agonist (ABT‐229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double‐blind placebo‐controlled trial , 2000, Alimentary pharmacology & therapeutics.

[66]  B. Yawn,et al.  Gastrointestinal tract symptoms among persons with diabetes mellitus in the community. , 2000, Archives of internal medicine.

[67]  P. Lambert,et al.  Antiemetic efficacy of prophylactic dimenhydrinate (Dramamine) vs ondansetron (Zofran) , 2000, Surgical Endoscopy.

[68]  P. Pasricha,et al.  The treatment of diabetic gastroparesis with botulinum toxin , 2000, American Journal of Gastroenterology.

[69]  A. Zinsmeister,et al.  Towards identifying optimal doses for alpha‐2 adrenergic modulation of colonic and rectal motor and sensory function , 2000, Alimentary pharmacology & therapeutics.

[70]  T. Abell,et al.  Long term ondansetron therapy is beneficial in patients with chronic nausea and vomiting , 2000 .

[71]  I. Petrakis,et al.  Induced-Hyperglycemia Attenuates Erythromycin-Induced Acceleration of Hypertonic Liquid-Phase Gastric Emptying in Type-I Diabetic Patients , 2000, Digestive Diseases.

[72]  A. Zinsmeister,et al.  Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome. , 2000, Gastroenterology.

[73]  D. Hensrud.  Nutrition screening and assessment. , 1999, The Medical clinics of North America.

[74]  R. Fisher,et al.  Cholinergic effects on human gastric motility , 1999, Gut.

[75]  G. Gerken,et al.  Prokinetics in Patients with Gastroparesis: A Systematic Analysis , 1999, Digestion.

[76]  D. Patterson,et al.  A double-blind multicenter comparison of domperidone and metoclopramide in the treatment of diabetic patients with symptoms of gastroparesisFig. 1 , 1999, American Journal of Gastroenterology.

[77]  P. Diemunsch,et al.  Antiemetic activity of the NK1 receptor antagonist GR205171 in the treatment of established postoperative nausea and vomiting after major gynaecological surgery. , 1999, British journal of anaesthesia.

[78]  M. Horowitz,et al.  Hyperglycemia attenuates the gastrokinetic effect of erythromycin and affects the perception of postprandial hunger in normal subjects. , 1999, Diabetes care.

[79]  Sridhar,et al.  Delta‐9‐tetrahydrocannabinol delays the gastric emptying of solid food in humans: a double‐blind, randomized study , 1999, Alimentary pharmacology & therapeutics.

[80]  R. McCallum,et al.  Demography, Clinical Characteristics, Psychological and Abuse Profiles, Treatment, and Long-Term Follow-up of Patients with Gastroparesis , 1998, Digestive Diseases and Sciences.

[81]  N. Leidy,et al.  Effect of Domperidone on the Health-Related Quality of Life of Patients With Symptoms of Diabetic Gastroparesis , 1998, Diabetes Care.

[82]  K. Freedland,et al.  Tricyclic Antidepressants for Functional Nausea and Vomiting (Clinical Outcome in 37 Patients) , 1998, Digestive Diseases and Sciences.

[83]  A. Karasawa,et al.  Effects of KW‐5092 on Antroduodenal Coordination and Gastric Emptying in Guinea‐pigs , 1998, The Journal of pharmacy and pharmacology.

[84]  J. Tack,et al.  Involvement of two different pathways in the motor effects of erythromycin on the gastric antrum in humans , 1998, Gut.

[85]  W. Chey,et al.  Differential effects of amitriptyline on perception of somatic and visceral stimulation in healthy humans. , 1998, American journal of physiology. Gastrointestinal and liver physiology.

[86]  M. Mulholland,et al.  Safety and long-term durability of completion gastrectomy in 81 patients with postsurgical gastroparesis syndrome. , 1998, The American surgeon.

[87]  N. Leidy,et al.  Domperidone in the management of symptoms of diabetic gastroparesis: efficacy, tolerability, and quality-of-life outcomes in a multicenter controlled trial. DOM-USA-5 Study Group. , 1998, Clinical therapeutics.

[88]  R A Ross,et al.  Gastric pacing improves emptying and symptoms in patients with gastroparesis. , 1998, Gastroenterology.

[89]  G. Wooten,et al.  Effect of chronic oral domperidone therapy on gastrointestinal symptoms and gastric emptying in patients with parkinson's disease , 1997, Movement disorders : official journal of the Movement Disorder Society.

[90]  G. Farrugia,et al.  Motilin and OHM-11526 activate a calcium current in human and canine jejunal circular smooth muscle. , 1997, The American journal of physiology.

[91]  J. Wishart,et al.  Blood Glucose Concentration Influences Postprandial Fullness in IDDM , 1997, Diabetes Care.

[92]  R. Mccallum,et al.  The effect of intravenous erythromycin on solid meal gastric emptying in patients with chronic symptomatic post‐vagotomy–antrectomy gastroparesis , 1997, Alimentary pharmacology & therapeutics.

[93]  H. Parkman,et al.  Erythromycin inhibits rabbit pyloric smooth muscle through neuronal motilin receptors. , 1996, Gastroenterology.

[94]  T. Abell,et al.  Symptom improvement from prokinetic therapy corresponds to improved quality of life in patients with severe dyspepsia , 1996, Digestive Diseases and Sciences.

[95]  B. Krevsky,et al.  Opioid and opioid-like drug effects on whole-gut transit measured by scintigraphy. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[96]  G. Barbara,et al.  Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. , 1996, Gastroenterology.

[97]  D. Drossman,et al.  Sexual and Physical Abuse and Gastrointestinal Illness: Review and Recommendations , 1995, Annals of Internal Medicine.

[98]  M. Camilleri,et al.  Mechanism of accelerated gastric emptying of liquids and hyperglycemia in patients with type II diabetes mellitus. , 1995, Gastroenterology.

[99]  H. Parkman,et al.  Gastrokinetic effects of erythromycin: myogenic and neurogenic mechanisms of action in rabbit stomach. , 1995, The American journal of physiology.

[100]  J. Chen,et al.  Clinical significance of gastric myoelectrical dysrhythmias. , 1995, Digestive diseases.

[101]  M. Samsom,et al.  Compliance of the proximal stomach and dyspeptic symptoms in patients with type I diabetes mellitus , 1995, Digestive Diseases and Sciences.

[102]  H. Parkman,et al.  Erythromycin inhibits pyloric muscle by releasing nitric oxide and VIP through neuronal motilin receptors , 1995 .

[103]  L. Troncon,et al.  Treatment of diabetic gastroparesis with oral clonidine , 1995, Alimentary pharmacology & therapeutics.

[104]  A. Zinsmeister,et al.  Impact of functional dyspepsia on quality of life , 1995, Digestive Diseases and Sciences.

[105]  W. Hasler,et al.  Mediation of hyperglycemia-evoked gastric slow-wave dysrhythmias by endogenous prostaglandins. , 1995, Gastroenterology.

[106]  B. Bravenboer,et al.  Hyperglycemia induces abnormalities of gastric myoelectrical activity in patients with type I diabetes mellitus. , 1994, Gastroenterology.

[107]  M. Horowitz,et al.  Disordered gastric motor function in diabetes mellitus , 1994, Diabetologia.

[108]  C. Wood,et al.  Effects of Motion Sickness and Antimotion Sickness Drugs on Gastric Function , 1994, Journal of clinical pharmacology.

[109]  M. Farthing,et al.  5-Hydroxytryptamine and human small intestinal motility: effect of inhibiting 5-hydroxytryptamine reuptake. , 1994, Gut.

[110]  A. Gaber,et al.  IMPROVEMENT IN AUTONOMIC AND GASTRIC FUNCTION FOLLOWING PANCREAS‐KIDNEY VERSUS KIDNEY‐ALONE TRANSPLANTATION AND THE CORRELATION WITH QUALITY OF LIFE1,2 , 1994, Transplantation.

[111]  J. Dent,et al.  Postprandial antropyloroduodenal motility and gastric emptying in gastroparesis--effects of cisapride. , 1994, Gut.

[112]  A. McCall,et al.  The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders. , 1993, Archives of internal medicine.

[113]  R. McCallum,et al.  Erythromycin: a motilin agonist and gastrointestinal prokinetic agent. , 1993, The American journal of gastroenterology.

[114]  R. McCallum,et al.  The treatment of idiopathic and diabetic gastroparesis with acute intravenous and chronic oral erythromycin. , 1993, The American journal of gastroenterology.

[115]  I. Lossos,et al.  Thiethylperazine Treatment of Gastroparesis Diabeticorum , 1992, The Annals of pharmacotherapy.

[116]  M. Vecchierini,et al.  Gastric emptying improvement after simultaneous segmental pancreas and kidney transplantation. , 1992, Transplantation proceedings.

[117]  B. Schirmer,et al.  Completion gastrectomy for refractory gastroparesis following surgery for peptic ulcer disease , 1991, Digestive Diseases and Sciences.

[118]  J. Wishart,et al.  Disordered gastric motor function in diabetes mellitus. Recent insights into prevalence, pathophysiology, clinical relevance, and treatment. , 1991, Scandinavian journal of gastroenterology.

[119]  D. Spyker,et al.  Subcutaneous metoclopramide in the treatment of symptomatic gastroparesis: clinical efficacy and pharmacokinetics. , 1991, The Journal of pharmacology and experimental therapeutics.

[120]  A. Zinsmeister,et al.  Long-term efficacy of oral cisapride in symptomatic upper gut dysmotility , 1991, Digestive Diseases and Sciences.

[121]  S. Pedersen,et al.  The influence of induced hyperglycaemia on gastric emptying rate in healthy humans. , 1990, Scandinavian journal of clinical and laboratory investigation.

[122]  J. Dent,et al.  Hyperglycaemia slows gastric emptying in Type 1 (insulin-dependent) diabetes mellitus , 1990, Diabetologia.

[123]  W. Rathmann,et al.  Visceral Afferent Neuropathy in Diabetic Gastroparesis , 1990, Diabetes Care.

[124]  H. Bergmann,et al.  Effects of the 5-HT3 receptor antagonist ICS 205-930 on fat-delayed gastric emptying and antral motor activity. , 1990, British journal of clinical pharmacology.

[125]  J. Najarian,et al.  Effects of pancreatic transplantation on diabetic neuropathy. , 1990, The New England journal of medicine.

[126]  R. Stern,et al.  Gastric emptying and gastric myoelectrical activity in patients with diabetic gastroparesis: effect of long-term domperidone treatment. , 1989, The American journal of gastroenterology.

[127]  R. Clouse,et al.  Gastrointestinal symptoms in diabetic patients: lack of association with neuropathy. , 1989, The American journal of gastroenterology.

[128]  J. Barnett,et al.  Serum glucose concentration as a modulator of interdigestive gastric motility. , 1988, Gastroenterology.

[129]  A. Emerson.  Foods high in fiber and phytobezoar formation. , 1987, Journal of the American Dietetic Association.

[130]  M. Camilleri,et al.  Relationship between impaired gastric emptying and abnormal gastrointestinal motility. , 1986, Gastroenterology.

[131]  M. Camilleri,et al.  Pyloric dysfunction in diabetics with recurrent nausea and vomiting. , 1986, Gastroenterology.

[132]  G. Maddern,et al.  Gastric and oesophageal emptying in insulin‐dependent diabetes mellitus , 1986 .

[133]  H. Poulsen,et al.  Effect of diazepam on drug absorption and gastric emptying in man. , 1985, British journal of anaesthesia.

[134]  R. McCallum,et al.  Effect of metoclopramide in diabetic gastroparesis. , 1985, Journal of clinical gastroenterology.

[135]  A. Ippoliti,et al.  A Multicenter Placebo-controlled Clinical Trial of Oral Metoclopramide in Diabetic Gastroparesis , 1983, Diabetes Care.

[136]  Victor C. Strasburger,et al.  Review and Recommendations , 1983 .

[137]  A. Alavi,et al.  Metoclopramide to treat gastroparesis due to diabetes mellitus: a double-blind, controlled trial. , 1982, Annals of internal medicine.

[138]  R. Robinson,et al.  Oral anticholinergics and gastric emptying , 1982, Clinical pharmacology and therapeutics.

[139]  J. Malagelada,et al.  Gastric motor abnormalities in diabetic and postvagotomy gastroparesis: effect of metoclopramide and bethanechol. , 1980, Gastroenterology.

[140]  E. Farber,et al.  The stasis syndrome. , 1956, Archives of Dermatology.

[141]  R. McCallum,et al.  Clinical response to gastric electrical stimulation in patients with postsurgical gastroparesis. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[142]  K. Verbeke,et al.  Randomised double-blind cross-over study evaluating the effect of intrapyloric injection of botulinum toxin on gastric emptying and symptoms in patients with gastroparesis , 2005 .

[143]  N. Kuriya,et al.  Prokinetic effect of AS-4370 on gastric emptying in healthy adults , 2004, European Journal of Clinical Pharmacology.

[144]  C. Perry,et al.  Aprepitant: a review of its use in the prevention of chemotherapy-induced nausea and vomiting. , 2004, Drugs.

[145]  Thomas R. Riley,et al.  A Randomized Double-blind Placebo-controlled Trial , 2004 .

[146]  Michael P. Jones,et al.  A systematic review of surgical therapy for gastroparesis , 2003, American Journal of Gastroenterology.

[147]  M. Camilleri,et al.  Selective effects of serotonergic psychoactive agents on gastrointestinal functions in health. , 2003, American journal of physiology. Gastrointestinal and liver physiology.

[148]  E. Wittbrodt,et al.  Low-dose oral naloxone reverses opioid-induced constipation and analgesia. , 2002, Journal of pain and symptom management.

[149]  C Wagner,et al.  Environmental and organizational determinants of quality management. , 2001, Quality management in health care.

[150]  M. Camilleri,et al.  Near-total completion gastrectomy for severe postvagotomy gastric stasis: Analysis of early and long-term results in 62 patients , 1999, Journal of Gastrointestinal Surgery.

[151]  A. Kalloo,et al.  Pain: the overlooked symptom in gastroparesis , 1999, American Journal of Gastroenterology.

[152]  D. Nelson,et al.  Venting percutaneous gastrostomy in the treatment of refractory idiopathic gastroparesis. , 1998, Gastrointestinal endoscopy.

[153]  D. Drossman.  Sexual and physical abuse and gastrointestinal illness. , 1995, Scandinavian journal of gastroenterology. Supplement.

[154]  Z. Itoh,et al.  Gastroprokinetic activity of nizatidine, a new H2-receptor antagonist, and its possible mechanism of action in dogs and rats. , 1993, The Journal of pharmacology and experimental therapeutics.

[155]  O. Nielsen,et al.  Gastric emptying and subjective symptoms of nausea: lack of effects of a 5-hydroxytryptamine-3 antagonist ondansetron on gastric emptying in patients with gastric stasis syndrome. , 1990, Digestion.

[156]  K. Kelly,et al.  Roux-Y gastrectomy for chronic gastric atony. , 1989, American journal of surgery.

[157]  R. McCallum,et al.  Effects of metoclopramide and bethanechol on delayed gastric emptying present in gastroesophageal reflux patients. , 1983, Gastroenterology.

[158]  G. Dotevall,et al.  The effect of pirenzepine and L-hyoscyamine on gastric emptying and salivary secretion in healthy volunteers. , 1981, Scandinavian journal of gastroenterology.

[159]  of efficacy: , 2022 .